This inventor holds 2 USPTO granted patents. Top assignees: National Cancer Center, Phc Corporation, Subaru Corporation. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2025-2026
Title: Yuma Suzuki - Innovator in Information Management
Introduction
Yuma Suzuki is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of information management, particularly in relation to cancer patient data. Her innovative approach combines technology with healthcare, aiming to improve patient outcomes through better information handling.
Latest Patents
Yuma Suzuki holds a patent for an "Information management apparatus and non-transitory computer-readable recording medium." This invention includes a processor designed to acquire first and second time information related to the processing of nucleic acids from cancer patients. The apparatus effectively stores individual patient information, linking it with relevant attributes of the cancer patient, thereby enhancing the management of critical health data.
Career Highlights
Throughout her career, Yuma has worked with esteemed organizations such as the National Cancer Center and PHC Corporation. Her experience in these institutions has allowed her to develop her expertise in the intersection of technology and healthcare.
Collaborations
Yuma has collaborated with notable colleagues, including Masahiro Okanojo and Tatsuya Matsuno. These partnerships have contributed to her innovative work and the advancement of her projects.
Conclusion
Yuma Suzuki is a pioneering inventor whose work in information management is making a difference in the healthcare sector. Her patent reflects her commitment to improving cancer patient care through innovative technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile